title: Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
abstract: Hereditary copper-associated hepatitis in dogs resembles Wilson's disease, a copper storage disease in humans. Values for urinary copper excretion are well established in the diagnostic protocol of Wilson's disease, whereas in dogs these have not been evaluated. The objectives of this study were to characterize both basal and D-penicillamine induced urinary copper, zinc and iron excretion in dogs in relation to hepatic copper concentration. Beagles, Beagle-Bedlington terrier cross-breeds homozygous for the COMMD1 gene mutation that causes copper toxicosis, and Labrador retrievers with normal or increased hepatic copper concentrations were investigated. The hepatic copper phenotype was determined by histological evaluation of liver biopsies and measurement of the hepatic copper concentration by instrumental neutron activation analysis. Urinary excretion of copper, iron and zinc was measured via inductively coupled plasma optical emission spectrometry under basal conditions and after oral administration of a single dose (20mg/kg bodyweight) of the chelator D-penicillamine. There was a rapid increase in urinary excretion of copper and zinc, but not iron after D-penicillamine administration. This increase was not different between dogs with high or normal hepatic copper concentrations. D-penicillamine-induced urinary copper excretion and the copper/creatinine ratio did not correlate with hepatic copper concentrations in the dogs studied, although basal urinary copper/zinc ratios did correlate with hepatic copper concentrations in Labrador retrievers. The latter parameter may be useful in diagnostic and follow-up protocols for copper-associated hepatitis in Labrador retrievers.
authors.affiliation: Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. h.fieten@uu.nl
authors.forename: H
authors.initials: H
authors.lastname: Fieten
authors.forename: S
authors.initials: S
authors.lastname: Hugen
authors.forename: T S G A M
authors.initials: TS
authors.lastname: van den Ingh
authors.forename: W H
authors.initials: WH
authors.lastname: Hendriks
authors.forename: J C M
authors.initials: JC
authors.lastname: Vernooij
authors.forename: P
authors.initials: P
authors.lastname: Bode
authors.forename: A L
authors.initials: AL
authors.lastname: Watson
authors.forename: P A J
authors.initials: PA
authors.lastname: Leegwater
authors.forename: J
authors.initials: J
authors.lastname: Rothuizen
mesh_terms: D000818:Animals; D002614:Chelating Agents / Q000627:therapeutic use*; D003300:Copper / Q000737:chemistry / Q000378:metabolism / Q000652:urine*; D004283:Dog Diseases / Q000188:drug therapy* / Q000235:genetics / Q000652:urine; D004285:Dogs; D007501:Iron / Q000652:urine*; D008099:Liver / Q000737:chemistry* / Q000378:metabolism; D008107:Liver Diseases / Q000188:drug therapy / Q000378:metabolism / Q000652:urine / Q000662:veterinary*; D010396:Penicillamine / Q000627:therapeutic use*; D015032:Zinc / Q000652:urine*
chemical_list: D002614:Chelating Agents; D003300:Copper; D007501:Iron; D010396:Penicillamine; D015032:Zinc
keywords: Canine; Copper; Hepatitis; Urine; Wilson’s disease